The factors to look for in defensives
There are two stocks in the healthcare and infrastructure space which can help investors gain defensiveness in their portfolio, according to T.Rowe Price.
The companies that would be best able to manage through this period will likely be companies with strong pricing power, differentiated products, good industry structure and defensive volumes.
This included Resmed in the healthcare space and Transurban in the infrastructure sector.
Randal Jenneke, head of Australian equities at T. Rowe Price, said: “Resmed for example has a large underpenetrated market, and despite various input and logistics cost pressures, has been able to pass through price increases given their dominant market share and current lack of reputable competition.
“In infrastructure, Transurban for example has built-in price increases for its contracts. The nature of its cost structure brings high EBIT margins and margin stability. Anecdotally, you know the cost of tolls are rising when every second taxi driver makes a point or two about it.”
Shares in Resmed were down 14.5% since the start of the year and 5% over one year to 30 June while Transurban was up 4% since the start of the year and 0.4% over one year.
Recommended for you
GQG Partners has marked its fifth consecutive month of outflows as its AI concerns lead to fund underperformance but overall funds under management increased to US$166.1 billion.
Apostle Funds Management is actively pursuing further partnerships in Asia and Europe but finding a suitable manager is a “needle in a haystack”.
Nuveen has made its private real estate strategy available to Australian wholesale investors, democratising access to a typically institutional asset class.
VanEck is expanding its fixed income range with a new ETF this week to complement its existing subordinated debt strategy which has received $1 billion in inflows this year.

